Indolin-2-one pyridine derivatives, preparation and...

Details Indolin-2-one pyridine derivatives, preparation and... Indolin-2-one pyridine derivatives, preparation and...

2007-03-16

2009-02-10

Morris, Patricia L (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S277700

Reexamination Certificate

active

07488743

ABSTRACT:
The disclosure concerns indolin-2-one pyridine compounds of general formula (I):wherein R0, R1, R2, R3, R4, Z and B have the meanings given in the description, and pharmaceutically acceptable salts thereof; and also pharmaceutical compositions comprising, processes for making and methods of using said compounds.

REFERENCES:
patent: 4882329 (1989-11-01), Lerch et al.
patent: 5594023 (1997-01-01), Wagnon et al.
patent: 2004/0059132 (2004-03-01), Foulon et al.
patent: 684791 (1998-04-01), None
patent: 0212481 (1987-03-01), None
patent: 0636608 (1995-02-01), None
patent: WO 95/18105 (1995-07-01), None
patent: WO 01/74775 (2001-10-01), None
Vippagunta et al., “Crystalline Solid”, Advanced Drug Delivery Reviews 48 (2001) 3-26.
Guillory (in Brittain ed), “Polymorphism, etc.,” NY: Marcel Dekker, Inc., 1999, 183-226.

Affiliated with

Also associated with

Rating

Indolin-2-one pyridine derivatives, preparation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indolin-2-one pyridine derivatives, preparation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolin-2-one pyridine derivatives, preparation and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4061746